KR
Distinguished in Peripheral Neuropathy
Check Dr. Katherine M. Ruzhansky's experience treating your condition:
About Dr. Katherine M. Ruzhansky

Katherine Ruzhansky is a Neurologist in Charleston, South Carolina. Ruzhansky has been practicing medicine for over 15 years and is rated as a Distinguished expert by MediFind in the treatment of Peripheral Neuropathy. She is also highly rated in 18 other conditions, according to our data. Her top areas of expertise are Myasthenia Gravis, Peripheral Neuropathy, Chronic Inflammatory Demyelinating Polyneuropathy, and Amyotrophic Lateral Sclerosis (ALS or Lou Gehrig's Disease). She is licensed to treat patients in South Carolina. Ruzhansky is currently accepting new patients.

Her clinical research consists of co-authoring 10 peer reviewed articles and participating in 3 clinical trials in the past 15 years. In particular, she has co-authored 5 articles in the study of Peripheral Neuropathy.

Insurance

MediFind strives to display the most accurate insurance information for every doctor. If you do not see your insurance listed for Dr. Katherine M. Ruzhansky it is best to call her office and ask if your insurance is accepted.

Accepts Medicare

Call to see if your plan is accepted.
Locations
135 Rutledge Ave, Charleston, SC 29425
Other Locations
1600 Midtown Ave, Mount Pleasant, SC 29464
Background & Education
Graduate Institution
Other, 2008
Specialties
Neurology
Hospital Affiliations
MUSC Health Black River Medical Center
Medical University Of South Carolina
Languages Spoken
English
Russian
Gender
Female
Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Doctors who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.


3 Clinical Trials

A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase 3 Trial to Evaluate Efficacy and Safety of Lenabasum in Dermatomyositis
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Trial of IMO-8400 in Patients With Dermatomyositis
View 2 Less Clinical Trials -

Save this doctor for later
Sign Up
Looking for the best doctor for you?
Start Here
Is this your doctor?
Find a second opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn more
Similar Doctors
Advanced
Advanced
Advanced